Natural Alternatives International Inc: Form 10-Q for the period ended Dec 31, 2025
Filed with the SEC on Feb 13, 2026 and accepted by EDGAR at Feb 13, 2026, 16:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-10-01 to 2025-12-31 | $34.8m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months2025-07-01 to 2025-12-31 | $72.5m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2025-10-01 to 2025-12-31 | $32.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2025-07-01 to 2025-12-31 | $65.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-10-01 to 2025-12-31 | $2.5m | us-gaap:GrossProfit |
| Gross profit | 6 months2025-07-01 to 2025-12-31 | $6.9m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2025-10-01 to 2025-12-31 | $4.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2025-07-01 to 2025-12-31 | $8.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-10-01 to 2025-12-31 | −$1.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2025-07-01 to 2025-12-31 | −$1.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-10-01 to 2025-12-31 | $224.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2025-07-01 to 2025-12-31 | $316.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-10-01 to 2025-12-31 | −$2.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2025-07-01 to 2025-12-31 | −$2.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-10-01 to 2025-12-31 | −$0.42 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2025-07-01 to 2025-12-31 | −$0.47 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-10-01 to 2025-12-31 | −$0.42 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2025-07-01 to 2025-12-31 | −$0.47 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-10-01 to 2025-12-31 | 6,007,793 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2025-07-01 to 2025-12-31 | 6,007,192 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2025-07-01 to 2025-12-31 | −$10.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2025-07-01 to 2025-12-31 | $2.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2025-07-01 to 2025-12-31 | $5.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-12-31 | $3.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $61.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $153.3m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $32.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $86.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-12-31 | $67.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-26-004118. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.